Levonorgestrel Intrauterine System
Earlier evidence found LNG-IUS reduced spotting more than expectant management at 6 months. Earlier cohort evidence found LNG-IUS more effective than HNR for postmenstrual spotting reduction. The LNG-IUS provides therapeutic hormone releas…
1 sources - 5 claims
Earlier evidence found LNG-IUS reduced spotting more than expectant management at 6 months. Earlier cohort evidence found LNG-IUS more effective than HNR for postmenstrual spotting reduction. The LNG-IUS provides therapeutic hormone release for up to 5 years. LNG-IUS insertion in the trial was performed during the non-menstrual phase under ultrasound guidance and without anaesthesia. The trial used the 52 mg Mirena levonorgestrel intrauterine system.